Moxifloxacin Ophthalmic

282 interactions 387 cited references

Also sold as: Moxeza® Vigamox Vigamox®

About Moxifloxacin Ophthalmic

Moxifloxacin ophthalmic solution is a fluoroquinolone antibiotic used to treat bacterial eye infections like pink eye. Read the full Moxifloxacin Ophthalmic drug information page →

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Aug 9, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Levoketoconazole Mesoridazine Pimozide Piperaquine Saquinavir Sparfloxacin

12 Contraindicated 251 Major 19 Moderate

All (282) Contraindicated (12) Major (251) Moderate (19)

Contraindicated

Moxifloxacin Ophthalmic Bepridil An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Cisapride Propulsid® Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Dronedarone Multaq Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Levoketoconazole Recorlev An increased risk of QT interval prolongation, an increased risk of serious hepatotoxicity and drug-induced liver injury Details Moxifloxacin Ophthalmic Mesoridazine An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Pimozide An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Piperaquine An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Saquinavir An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Sparfloxacin An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Terfenadine An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Thioridazine An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Ziprasidone Geodon An increased risk of QT interval prolongation Details

Major

Moxifloxacin Ophthalmic Acarbose Prandase® Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Adagrasib Krazati An increased risk of QT interval prolongation, torsade de pointes, polymorphic ventricular tachycardia, other serious arrhythmias Details Moxifloxacin Ophthalmic Albiglutide Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Alfuzosin UroXatral Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Alogliptin Nesina Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Amiodarone Nexterone Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Amisulpride Barhemsys Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Moxifloxacin Ophthalmic Amitriptyline Elavil Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Anagrelide Agrylin Increased anagrelide exposure and increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Apomorphine Apokyn Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Aripiprazole Abilify An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Aripiprazole Lauroxil Aristada An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Arsenic Trioxide Trisenox Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Artemether An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Asenapine Saphris Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Astemizole Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Atazanavir Reyataz Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Azathioprine Azasan An increased risk of hepatotoxicity Details Moxifloxacin Ophthalmic Azithromycin AzaSite Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Bedaquiline Sirturo Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Betamethasone Betavet An increased risk of tendon rupture Details Moxifloxacin Ophthalmic Budesonide Entocort An increased risk of tendon rupture Details Moxifloxacin Ophthalmic Buprenorphine Belbuca An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Bupropion Aplenzin Increased risk of seizures Details Moxifloxacin Ophthalmic Canagliflozin Invokana Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Ceritinib Zykadia An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Chloroquine Aralen® Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Chlorpromazine Increased risk of QT interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.